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Abstract
Using a novel three-dimensional (3D) approach, we tracked histological changes to elucidate the earliest stages of renal clear cell neoplasia in 
normal kidney tissue of patients with von Hippel-Lindau (VHL) disease. Tissue blocks of interest were procured, serially sectioned, and 3D 
reconstruction of the entirety of pathologic events was performed. The results reveal an abundance of foci with aberrant clear cell proliferation 
that initially develop along the tubular lining, but have the potential to aggregate within individual tubules. This stage is followed by the exten-
sion of clear cell aggregates beyond the tubular basement membrane, which allows for the recruitment of angiogenesis derived from interstitial 
vasculature. The results suggest that the most frequent pathologic event in VHL kidneys is the presence of isolated or aggregated clear cells 
within the tubular epithelium, potentially developing further into a protracted process of neoplasia. The abundance of independent pathologic 
events in VHL kidneys confirms developmental mechanisms to precede tumor initiation. To our knowledge, this is the first report demonstrating 
that tracking of histologic changes in the 3rd dimension enables the confirmation of the sequence of events from the earliest pathologic change 
in the VHL kidney to the neoplastic stage. This approach is not only useful for visualization and quantification of pathologic changes but also 
for targeted sampling allowing selective analysis of the earliest stages of clear cell carcinogenesis. 
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Patients with VHL disease develop tumors in the nervous sys-
tem, kidneys, endolymphatic sac, epididymis or broad liga-
ment, neuroendocrine tumors, and pheochromocytomas (1). 
The presence of abundant microscopic tumor precursor 
structures in the nervous system of patients with von Hippel- 
Lindau (VHL) disease has been previously demonstrated 
(2, 3). The cells of these precursor structures were shown to 
be immature (3, 4), and several lines of evidence suggest that 
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pathologic cells were generated during early organ develop-
ment (5). The growth pattern of precursor structures appears 
highly protracted, with only a subset of them developing into 
frank tumors (3). Precursor structures defy categorization as 
teratomatous, tumorous, or dysplastic, and the designation 
of a developmentally arrested structural element (DASE) 
has also been previously suggested (4). In VHL disease, the 
inactivation of the VHL wild-type allele (“second hit”) is 
a prerequisite for the formation of DASEs. Since a major-
ity of the DASEs never develop into frank tumors, two-hit 
inactivation of the VHL gene is necessary but insufficient 
for tumor development. A key question remains the nature 
of the “third hit” that would transform DASEs into frank 
tumors.
Similarly, the epididymides of male VHL patients reveal 
VHL-deficient, developmentally aberrant structures that 
may give rise to frank tumors (6). In VHL disease, both the 
epididymides and the kidneys independently generate meso-
nephros or metanephros-derived tumors (1). Interestingly, 
epididymal neoplasia is generally benign, whereas renal clear 
cell carcinoma is associated with metastatic spread, and sig-
nificant morbidity and mortality. 
Seminal studies that have demonstrated abundant foci 
of clear cell proliferation in the VHL kidney (7, 8) had 
prompted us to investigate on a better characterization of 
these proliferations and determine the sequence of their evo-
lution. We started investigating tissue sections from tumor-
free, normal-appearing kidney tissue for developmental 
aberration and earliest steps of tumorigenesis (unpublished 
data), in analogy to previous studies on other tumorigenic 
sites in VHL disease, for better clarification of the earliest 
stages of renal tumorigenesis in VHL disease (1). Most fre-
quently observed pathologic events in VHL kidney sections 
were either isolated clear cells within a renal tubule or two or 
more clear cells that were adherent to each other, likely repre-
senting the result of an amplification event. Higher accumu-
lations of clear cells along the tubular lining and clustering 
of clear cells within renal tubules appeared to be in the conti-
nuity of smaller preceding events. 
Previous studies, however, performed an analysis of sin-
gle random tissue sections that only allowed for limited 
interpretation of the evolution of histologic changes (7, 8). 
Using a novel three-dimensional (3D) algorithm consisting 
of methodological sampling and histological tracking (later 
developed in the text), we tracked those lesions to confirm 
their relationship to each other. This algorithm allowed us 
to observe that microscopic clear cell proliferation followed 
a predictable pattern covering an entire morphological spec-
trum of histologic lesions from an isolated clear cell to tum-
origenic clear cell proliferation. 
In this study we first verified the reproducibility of our 3D 
algorithm developed on one VHL kidney (training set) on 
a larger cohort of VHL and non-VHL kidneys (validation 
set) from the inspiration of the presentation of the results at 
the 2014 VHL meeting in Madrid (9) along with a review of 
hypothetical histological pathways (10). 
Materials and Methods
Tissues
Seven kidneys of seven different patients were obtained at 
autopsy and used for this study after complete fixation in 
10% buffered formalin. Four kidneys were from patients 
with germline mutation of the VHL gene and established 
diagnosis of VHL disease (designated as “VHL kidneys”). 
All patients had different VHL disease-associated tumors 
including renal clear cell carcinoma (CCC), and had died 
between ages 50 and 65 years. Three control kidneys from 
patients with sporadic renal cell carcinoma, aged between 
55 to 70 years, were also used for this study (designated as 
 “sporadic kidneys”). 
The kidneys used for this study had already been partially 
sectioned for original diagnostic evaluation, and portions of 
tumor nodules had been excised for histologic confirmation 
of renal CCC. In general, VHL kidneys showed involvement 
by numerous tumor nodules and cysts of variably size. In 
contrast, sporadic kidneys showed a solitary cancerous nod-
ule, whereas the remaining kidney tissue appeared without 
pathologic changes. 
Processing of kidneys
The primary goal of this study was to identify and analyze 
renal tissues with no or only minimal grossly visible patho-
logic changes. All kidneys were sectioned randomly into 
maximally 10 cm × 1.5 cm × 1.0 cm columnar cuboids. 
The obtained cuboids of each kidney were inspected, and 
cuboids showing any grossly visible tumor were rejected. 
Of the remaining cuboids, the cuboid with the least grossly 
visible pathologic changes was identified and selected as the 
cuboid of interest (COI). For each kidney under study, one 
COI was selected (n = 7).
COIs were then sliced into 0.3 cm × 1.5 cm × 1.0 cm 
blocks and a maximum of 30 blocks per COI was created. 
All tissue blocks without grossly visible pathologic change 
were paraffin- embedded. An initial section was taken from 
each block and stained with hematoxylin and eosin (H&E) 
for histologic evaluation and identification of the block of 
interest for 3D reconstruction. 
Block of interest (BOI)
The purpose of the BOI selection was to identify the most 
informative kidney tissue block for 3D reconstruction for 
each case under study. The initial H&E sections for each 
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A and B or type D and E events. Microsoft Excel software 
was used for the documentation and graphics. 
Results 
The gross appearance of VHL kidneys was different from 
that of sporadic kidneys. VHL kidneys contained numer-
ous diffusely scattered small tumor nodules, whereas spo-
radic kidney tissue showed a solitary tumor only (Figure 1). 
As previously processed with our training set, kidneys were 
sliced, and the slices were subdivided into cuboids. The 
selected cuboids of interest were subdivided into tissue 
blocks from which tissue BOIs were identified and subjected 
to serial sectioning and 3D analysis (Figure 2). Upon histo-
logic investigation, an abundance of microscopic pathologic 
events was identified and annotated. The majority of the 
block allowed for examination of the extent of unspecific 
pathologic changes including reactive inflammation, fibro-
sis, and/or hemorrhage. Tissue blocks of some COIs were 
rejected because of the presence of unspecific pathologic 
changes. Among the acceptable tissue blocks, blocks contain-
ing renal cortex were selected, and a BOI was selected based 
on the absence of unspecific histopathologic changes and the 
quality of histological preservation. For each case, one BOI 
was subjected to 3D analysis.
3D reconstruction of pathologic events
Each BOI was serially sectioned into 5 um-thick sections, 
and each section was placed on an individual glass slide 
and labeled consecutively. Every tenth section was stained 
with H&E and scanned using a Ventana iScan slide scanner 
(Roche, Basel, Switzerland). Unstained sections were pre-
served for possible follow-up studies. 
All H&E slides were consecutively evaluated for cytologic 
and structural differences, compared with regular renal his-
tology using high power magnification. Any cytologic/struc-
tural difference was separately annotated and categorized 
using iScan image viewer software. This process allowed us 
to obtain a pathologic event count within the BOI, which 
could be compared with sporadic or other VHL kidneys (see 
below).
Quantitative assessment of pathologic events
The most frequently observed pathologic events in the VHL 
kidney sections could be defined either as an isolated clear 
cell within a renal tubule or as two or more clear cells adher-
ent to each other, likely representing the result of an ampli-
fication event. Since the microscopic clear cell proliferations 
followed a predictable pattern, all pathologic clear cell events 
could be conveniently separated in five types of pathologic 
lesions by considering the lesion presentation and size in 
ascending order: (i) Type A-single clear cells; Type B-small 
chain of clear cells; (iii) Type C-large chain of clear cells; 
(iv)  Type D-intratubular clear cell cluster; and (v) Type E- 
invasive clear cell cluster.
All type C to E events were independently annotated and 
counted in each consecutive section. If  a deeper section 
showed the continuation of an event, the event retained the 
same annotation. By this approach, we were able to count 
the exact number of events in each BOI. Type A and type B 
events were so abundant that 3D counts were obtained from 
a 1mm × 1mm representative area within the section and 
from the corresponding 1mm x 1mm areas in the consecutive 
sections. In other words, a 1mm × 1mm × 3 mm (BOI thick-
ness) column designated as “micro-BOI” was assessed within 
the BOI. For type C lesions, both BOI and micro-BOI counts 
were obtained to allow separate comparison with either type 
VHL Kidney
Sporadic Kidney
Figure 1: Example of VHL kidney cuboid, sectioned into 
consecutive tissue blocks (top); cystic structures or small 
tumor nodules are visible in most of the blocks; chosen tis-
sue blocks of interest (BOI, arrow) show no or only mini-
mal pathologic changes grossly; in contrast, sporadic kidney 
reveals no obvious pathologic changes in non-tumorous 
parenchyma (bottom).
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pathologic events were characterized as variable amounts of 
intratubular clear cells. Figure 3 shows the categorization of 
the event into five different types, reflecting ascending order 
in sizes.
Type A: an isolated clear cell within  
a renal tubule 
Clear cells are a well-known phenomenon in the VHL 
 kidney (8). They have been identified as VHL-deficient, with 
activation of hypoxia-inducible factor (HIF) and upregu-
lation of target proteins including carbonic anhydrase IX 
(CAIX) (8). An empty appearance and enlarged cytoplasm 
with a round nucleus denote a clear cell (Figure 3). Among 
the annotated pathologic events, single clear cells (type A 
events) were the most frequent. The number of single clear 
cells was counted within a micro-BOI representing 1% of the 
block volume (Figure 4). Within the evaluated micro-BOI 
areas, the numbers of isolated clear cells ranged from 70 to 
228 in four VHL kidneys (Figure 5). In contrast, only six to 
12 isolated clear cells were identified in sporadic kidneys.
Type B: small clear cell chain
A small clear cell chain is two or more clear cells that are 
adherent and replace less than 50% of a tubular circumfer-
ence (type B event, Figure 3). Like type A events, they were 
also counted within the micro-BOI column. Within the 
selected micro-BOIs of VHL kidneys, the numbers of small 
clear cell chains ranged from 29 to 65 events. In contrast, the 
micro-BOIs of sporadic kidneys contained no or maximally 
one event (Figure 4).
Type C: large clear cell chain
A large clear cell chain has multiple adherent clear cells 
that replace more than 50% of the tubular circumference 





















Figure 2: Processing of sporadic and VHL kidneys; A, slicing of kidney into cuboids is followed by selection of cuboid of  interest 
(COI); B, sectioning into tissue blocks is followed by selection of normal-appearing blocks and creation of initial HE-stained 
section for selection of block of interest (BOI); C, serial sectioning of BOI and staining of representative sections; D, scanning 
of representative sections; E, evaluation and annotation of HE-stained sections; F, 3d tracking and reconstruction of pathologic 
events along consecutive levels. 
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Figure 3: Most frequently observed pathologic events in 
VHL kidney. Events can be identified on H&E-stained sec-
tions (left) or by immunohistochemistry for CAIX (right). 
Representative samples of sections unrelated to each other 
are shown. Type A, single clear cell; type B, small chain of 
clear cells; type C, large chain of clear cells; type D, intratu-
bular clear cell cluster; type E, invasive clear cell cluster. 
the micro-BOI column and in the entire block. Within the 
selected micro-BOIs of VHL kidneys versus the entire sec-
tion surface, the numbers of large clear cell chains ranged 
from two to 25 events versus 99 to 220 events (Figure 4). In 
contrast, the micro-BOIs of sporadic kidneys contained no 
or maximally one large clear cell chain event versus none. 
Type D: intratubular clear cell cluster
Intratubular clear cell clusters were defined as clusters of 
clear cells that filled and frequently expanded a renal tubule 
(Figure 3). In contrast to type B and C events, the intratu-
bular clear cell cluster showed multilayered growth from 
two layers to full lumen occupancy and occasional tubular 
expansion. The entire surface of each section was evalu-
ated. Between 14 and 63 intratubular clear cell clusters were 
detected in the BOIs of VHL kidneys, whereas none were 
found in control sporadic kidney (Figure 4). 
Type E: invasive clear cell cluster 
Intratubular clear cell clusters (Type D) were frequently 
observed in VHL kidneys. Upon analysis in 3D tracking, we 
identified occasional and focal destruction of tubular epithe-
lium and basement membrane indicative of amplification, 
proliferation, and invasion of clear cells beyond the basal 
membrane into the renal interstitium separately categorized 
as Type E, invasive clear cell clusters (Figure 3). Between 
1 and 6 Type E events were detected in four VHL kidneys. 
Type E events were absent in non-VHL control kidneys.
Discussion
Renal tubular clear cell change resembling VHL-deficient 
clear cells can occur secondary to metabolic/toxic etiolo-
gies. These include changes secondary to toxins and Alport 
nephropathy (11–13), osmotic tubulopathy seen in diabetes 
and acute kidney injury (13) or changes after infusion of 
radiologic contrast media (14). These changes show prom-
inent cytoplasmic vacuolization with preservation of the 
epithelial brush border. In contrast, VHL-deficient clear 
cells are without brush border or any other morphologic 
evidence of tubular differentiation. They are distinct from 
tubular epithelium, which appears to be gradually replaced 
by proliferating clear cells. Further, VHL-deficient clear cells 
show consistent strong positive immunoreactivity with anti-
CAIX (8). This consistent immunoreactivity with anti-CAIX 
differentiates VHL-deficient clear cell clusters from clear cell 
clusters in the sporadic kidney, which occur rarely and are 
negative for CAIX (15). We did not detect any clear cell clus-
ters in our three sporadic, serially sectioned control kidneys.
Application of imaging techniques established early on 
that renal tumors in VHL disease frequently occur in multi-
plicity (16). Most radiologically detected lesions are small and 
can be surveilled until the index tumor reaches 3 cm in size, at 
which malignant metastatic spread can occur (17). On purely 
histopathological criteria, precancerous and precursor lesions 
in the VHL kidney have been previously appreciated (18, 19). 
Beyond analysis of grossly or radiologically visible tumor 
analysis, Walther et al. (7) investigated normal-appearing 
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Blue: Type B Green: Type C Yellow: Type D Red: Type E
Level 2
Level 3
Figure 4: Diagram of VHL kidney block of interest containing pathologic events of different sizes which are displayed in dif-
ferent colors. The histologic presentation of different section levels into the block is shown (annotated as “Level 1”, “Level 2”, 
“Level 3”). Also demonstrated is the micro-BOI column which was represented by a 1mm x 1mm field on each consecutive slide 
and used for counting type A, B and C events. Consecutive sections through the block allowed for reconstruction of size and 
shape of each annotated pathologic event. 
renal tissues from VHL patients (7). In the “grossly normal” 
VHL kidney, investigators detected an abundance of small 
clear cell tumors in the VHL kidney with partial resemblance 
to invasive clear cell clusters identified in this study. Single 
H&E-stained sections of paraffin blocks were investigated to 
document and extrapolate the frequency of tumors and were 
estimated as 600 per VHL kidney (7). 
In selected sections of VHL kidney, Mandriota et al. (8) 
described an abundance of either isolated or small chains of 
tubular cells with VHL gene inactivation. Clear cells were 
confirmed to be positive for CAIX as a consequence of VHL 
gene inactivation. By laser confocal microscopy and immu-
nohistochemistry combined with fluo-rescent in situ hybrid-
ization, single CAIX-positive clear cells were subsequently 
confirmed to be VHL gene-deleted (20). Based on these and 
additional unpublished findings (9, 21), a developmental 
model has been suggested, proposing the progression of sin-
gle VHL-deleted cells via cellular amplifi-cation to cysts and 
tumorlets (10).
By using 3D tracking, we demonstrate that early stages of 
cellular amplification occur along the tubular lining. A sub-
sequent key stage appears to be a neoplastic progression into 
intratubular clusters, allowing for voluminous expansion. 
The genetic and epigenetic mechanisms of this event remain 
to be clarified. It is also unknown whether penetration of the 
tubular basement membrane occurs by an active invasion of 
transformed cells or results “passively” from uncontrolled 
expansion. Of particular interest in VHL disease has been 
the relationship between cysts and tumors. Further studies 
need to clarify whether cysts and tumors develop via inde-
pendent mechanisms or are merely variations of an essen-
tially uniform pathogenetic process. While consequences of 
dysregulation of VHL and HIF pathways provide numerous 
potential clues (10), our approach may be helpful to obtain in 
situ evidence in human tissues in the future. 
Our 3D tracking approach allows us to significantly 
expand our understanding of early tumorigenesis by pro-
viding numerical quantification of pathologic events. By this 
quantification, we conclude that pathologic events of lower 
complexity are consistently more numerous than pathologic 
events of higher complexity. Structural details will allow 
for lesion volume calculation and observations of relation-
ships between lesion volume and histopathological change. 
In addition, enhanced structural detail can be obtained 
by the utilization of adjacent sections that were initially 
kept unstained, but could be subjected to special stains or 
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Figure 5: Numbers of pathologic events in micro-BOIs (left, A-C) and BOIs (middle, D-F) in VHL kidneys and control kidneys. 
Control results are only shown for micro-BOI counts (right, G, H); control results were consistently negative for large chains, 
intratubular clear cell clusters or invasive clusters. In all blocks, lower complexity events numerically exceed consecutive events 
of higher complexity. 
immunohistochemical preparations of interest later in time 
(Figure 6). 
Our results demonstrate that smaller clear cell aggregates 
that precede tumorlet formation are numerically far more 
abundant. A prerequisite for our study was a procurement 
algorithm that provided the most informative tissues by tar-
geted gross tissue examination and triage, followed by further 
quality triage by histological examination of selected blocks. 
In contrast to routine diagnostic tissue procurement, we 
triaged all tissue blocks to identify the most unremarkable- 
appearing and best-preserved representative tissue blocks 
for each kidney. The entire kidneys were sectioned into 
cuboids of 1.0 cm × 1.5 cm base area with a maximum of 10 
cm in length. All cuboids containing visible pathology were 
rejected, and the most normal-appearing cuboid was selected 
from each kidney. Consecutive processing and microscopic 
analysis of all blocks sectioned from the selected cuboid 
allowed for the selection of BOIs for a more detailed study. 
In the BOIs of VHL kidneys, we detected a frequency of 
smallest microscopic pathologic events (type A, B, C) that 
by far exceeded the frequency of clear cell tumorlet clusters, 
previously described by Walther et al. (7). More specifically, 
in all examined tissue blocks, the number of smaller- sized 
clear cell events consistently exceeded that of larger- sized 
events, providing evidence that clear cell structures develop 
from the amplification of single VHL-deleted clear cells. 
That only a tiny proportion of smaller-sized events pro-
gresses into larger-sized events provides further evidence 
for the protracted character of tumorigenesis, previously 
described in the nervous system of VHL patients (22). This 
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as 600 approximately (7), the number of smaller clear cell 
events is exponentially larger. It thus remains challenging 
to explain how thousands or millions of tubular cells would 
independently be subjected to a second hit. A more compel-
ling explanation for the frequency of VHL gene function 
loss is the occurrence of deletion events during metanephric 
renal development, resulting in persistent VHL-inactivated 
or stem cells within the tubular lining. 
Evidence of different developmental states of proximal 
tubular cells has been provided, as putative progenitor cells 
have been identified in the human kidney, scattered through-
out the proximal tubules (24, 25). In histological resem-
blance, the VHL kidney appears to represent a “mosaic” 
Slide 91 Slide 99 Slide 100 Slide 101
Slide 102 Slide 103 Slide 104 Slide 105
Slide 110 Slide 111 Slide 112 Slide 121
Figure 6: Selected images of 3D reconstruction of a single pathologic event in VHL kidney. The event was originally identified 
on slides #101 and #111 and classified as type D event (clear cell cluster). Consecutive unstained sections were used and variably 
stained for more detailed reconstruction. The event is contained between sections #91 and #121 which show no related patho-
logic change. The event is characterized by a tubule obstructed by clear cells (demonstrated in sections #99 to #112). While the 
tubule is expanded by the clear cell proliferation, Jones special stain reveals intact tubular basement membrane (slides #100, 
#103, #105, #110, #112). Immunohistochemistry for CD31 shows increased capillarization in direct vicinity to the clear cell 
cluster (slides #99 and #102) as previously shown by Mandriota et al. 
protracted progression may be the morphological equiva-
lent of a linear evolutionary subtype of tumor progression 
identified by whole-genome analysis of renal cancer tissues 
in VHL disease (23).
Our 3D tracking approach allowed us to visualize 
and examine many microscopic clear cell changes, which 
consistently revealed strict dichotomic presentation of 
VHL-deficient clear cells and normal tubular cells, without 
intermediary cytology or microarchitecture that would sug-
gest transition of the renal tubular cell to clear cell. This out-
come agreed to the microscopic change demonstrated by a 
previous study (8). While the number of invasive clear cell 
clusters in VHL kidney has been previously extrapolated 
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composed of wild-type and VHL-inactivated cells, with a 
small subset of VHL-inactivated cells amplifying along a 
defined sequence of progression. 
Male patients with VHL disease develop CCC in the kid-
ney and cystadenoma in the epididymis (6). Both tumors 
share a mesonephric origin but show distinct biological 
behavior with only CCC harboring malignancy potential. 
Of special interest may be the profound difference between 
the earliest neoplastic proliferation. Via hypoxic signaling 
beyond the basement membrane, early intratubular renal 
clear cell change is associated with angiogenesis in the 
adjacent stroma (8), without affecting tubular microarchi-
tecture. In contrast, hypoxic signaling of early intraductal 
clear cell change in the epididymis is associated with micro-
papillary intraductal growth. The characteristic changes of 
mesonephric clear cell proliferation in the VHL kidney – 
 replacement of tubular cells and clustering – are not present 
in the VHL epididymis. Of interest are, therefore, not only 
differences in proliferative behavior of VHL-deficient meso-
nephric cells but also differences in stromal response. 
In summary, our approach to tissue grossing and 3D his-
tological tracking aids in the detailed analysis of earliest 
cytologic and structural changes in organs affected by VHL 
disease. It allows for the identification of large numbers of 
potential precursor structures including numerical and struc-
tural quantification. In addition, histologically controlled 
unstained sections can be retained for additional studies 
including specialized histology or macro/microdissection 
for advanced analysis. Even though the applied approach 
is time-consuming, it has been highly rewarding. This study 
proved that the 3D algorithm used is reproducible, and the 
study findings are robust and reliable. We hope that this 3D 
algorithm will pave the road to better-targeted sampling for 
future studies, which will provide enhanced insights into 
VHL kidney tumorigenesis. 
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